This evening program combines cocktail networking and jazz, dinner, and a live panel discussion that examines how to translate cutting‑edge cell and gene therapy science into GMP-compliant, commercially viable manufacturing. Attendees will hear real‑world perspectives on development challenges, regulatory considerations, and strategic innovations shaping the next generation of advanced therapy manufacturing, followed by audience Q&A and additional networking over dessert.

Industry leaders from organizations such as Kite Pharma, Genefab, Minaris Advanced Therapies, and Neurona Therapeutics will share insights on quality, technical development, and global MSAT for cell and gene therapies. The schedule runs from 5:00–9:00 p.m., including registration, networking, dinner, panel, Q&A, and closing networking reception.